DadFinStart your free week
DadFin › Stocks › Healthcare › SRTS

Sensus Healthcare, Inc. (SRTS) stock score

Healthcare · Medical Devices · United States

$2.86 ▼ -2.05% today

47.3
Dad Score, out of 100
middling

Sensus Healthcare, Inc. (SRTS) is a Medical Devices company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 47.3 out of 100 on the Dad Score, a middling reading that places the business ahead of 47% of the 5,699 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #483 of 954. Its strongest axes are price action, conviction and liquidity; its weakest are quality and growth.

Scores from the run of Nov 7, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Average
Quality
Weak
Growth
Weak
Price action
Strong
Risk
Average
Conviction
Above average
Liquidity
Strong
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)—
P/E (forward)-16.5×
Dividend yield0.00%
Return on capital-19.9%
Operating margin-138.9%
Revenue growth (YoY)-34.3%
FCF yield1.3%
Net debt / EBITDA3.00×
Piotroski F-Score3 / 9
52-week change-34.1%
Market cap$47M
Next earningsNov 12, 2026

What subscribers see on SRTS

Start your free weekSubscriber? Open the full research →

Medical Devices peers

StockCompanyDad ScoreBandMarket cap
ABTAbbott Laboratories98.4strong$190.4B
MDTMedtronic plc99.9strong$130.2B
SYKStryker Corporation92.9strong$124.1B
BSXBoston Scientific Corporation91.9strong$62.0B
EWEdwards Lifesciences Corporation93.9strong$58.7B
GEHCGE HealthCare Technologies Inc.99.4strong$37.2B
PHGKoninklijke Philips N.V.97.8strong$29.7B
DXCMDexCom, Inc.66.3middling$29.6B

Prices from DadFin's live feed (refreshed about every 30 minutes in the session); scores from the weekly run of Nov 7, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.